Drugs and Devices

FDA approves new drug for hyperkalemia

On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares